Emodin alleviates arthritis pain through reducing spinal inflammation and oxidative stress
Open Access
- 19 December 2022
- journal article
- research article
- Published by SAGE Publications in Molecular Pain
- Vol. 18
Abstract
Chronic pain is the predominant problem for rheumatoid arthritis patients, and negatively affects quality of life. Arthritis pain management remains largely inadequate, and developing new treatment strategies are urgently needed. Spinal inflammation and oxidative stress contribute to arthritis pain and represent ideal targets for the treatment of arthritis pain. In the present study, collagen-induced arthritis (CIA) mouse model was established by intradermally injection of type II collagen (CII) in complete Freund’s adjuvant (CFA) solution, and exhibited as paw and ankle swelling, pain hypersensitivity and motor disability. In spinal cord, CIA inducement triggered spinal inflammatory reaction presenting with inflammatory cells infiltration, increased Interleukin-1β (IL-1β) expression, and up-regulated NOD-like receptor thermal protein domain associated protein 3 (NLRP3) and cleaved caspase-1 levels, elevated spinal oxidative level presenting as decreased nuclear factor E2-related factor 2 (Nrf2) expression and Superoxide dismutase (SOD) activity. To explore potential therapeutic options for arthritis pain, emodin was intraperitoneally injected for 3 days on CIA mice. Emodin treatment statistically elevated mechanical pain sensitivity, suppressed spontaneous pain, recovered motor coordination, decreased spinal inflammation score and IL-1β expression, increased spinal Nrf2 expression and SOD activity. Further, AutoDock data showed that emodin bind to Adenosine 5‘-monophosphate (AMP)-activated protein kinase (AMPK) through two electrovalent bonds. And emodin treatment increased the phosphorylated AMPK at threonine 172. In summary, emodin treatment activates AMPK, suppresses NLRP3 inflammasome response, elevates antioxidant response, inhibits spinal inflammatory reaction and alleviates arthritis pain.Keywords
Funding Information
- Research Project of Hubei Provincial Department of Education (Q20212804, B2021227 , B2021230)
- National Natural Science Foundation of China (81971066, 81901149 , 32100823)
This publication has 45 references indexed in Scilit:
- Nrf2 signaling pathway: Pivotal roles in inflammationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2017
- AMPK Facilitates Nuclear Accumulation of Nrf2 by Phosphorylating at Serine 550Molecular and Cellular Biology, 2016
- AMPK Phosphorylation Modulates Pain by Activation of NLRP3 InflammasomeAntioxidants & Redox Signaling, 2016
- Nuclear Factor E2-related Factor-2 (Nrf2) Is Required for NLRP3 and AIM2 Inflammasome ActivationJournal of Biological Chemistry, 2014
- The Crosstalk Between Nrf2 and AMPK Signal Pathways Is Important for the Anti-Inflammatory Effect of Berberine in LPS-Stimulated Macrophages and Endotoxin-Shocked MiceAntioxidants & Redox Signaling, 2014
- Activation of Spinal NF‐κB/p65 Contributes to Peripheral Inflammation and Hyperalgesia in Rat Adjuvant‐Induced ArthritisArthritis & Rheumatology, 2013
- Promotion of adiponectin multimerization by emodin: A novel AMPK activator with PPARγ‐agonist activityJournal of Cellular Biochemistry, 2012
- Oxidative stress, inflammation, and cancer: How are they linked?Free Radical Biology and Medicine, 2010
- Ligand docking and binding site analysis with PyMOL and Autodock/VinaJournal of Computer-Aided Molecular Design, 2010
- Benefits and Risks of Minocycline in Rheumatoid ArthritisDrug Safety, 2000